Literature DB >> 23788556

In Vivo Rapid Assessment of Compound Exposure (RACE) for Profiling the Pharmacokinetics of Novel Chemical Probes.

Danielle McAnally1, Michael Vicchiarelli, Khandaker Siddiquee, Layton H Smith.   

Abstract

The Rapid Assessment of Compound Exposure (RACE) assay is an easy and efficient method for estimating the pharmacokinetic parameter of exposure (AUC: area under the curve) of novel chemical probe compounds in mice. RACE is a truncated and compressed version of a traditional comprehensive in vivo pharmacokinetics study. The method uses a single standard formulation, dose, route of administration, and a small cohort of mice (n = 4). Standardized protocols and an abbreviated sample collection scheme reduce the labor needed to perform both the in-life and bioanalytical phases of the study. The procedure reduces the complexity of data analysis by eliminating all but one calculated pharmacokinetic parameter; estimated exposure (eAUC20-120), a parameter that is sufficient to rank order compounds based on exposure, but is also easily determined by most software using the simple trapezoidal rule. The RACE assay protocol is readily applicable to early/exploratory studies of most compounds, and is intended to be employed by laboratories with limited expertise in pharmacology and pharmacokinetics. Curr. Protoc. Chem. Biol. 4:299-309
© 2012 by John Wiley & Sons, Inc.

Entities:  

Keywords:  exposure; high‐throughput; in vivo; pharmacokinetics; rapid

Year:  2012        PMID: 23788556      PMCID: PMC3694733          DOI: 10.1002/9780470559277.ch120072

Source DB:  PubMed          Journal:  Curr Protoc Chem Biol        ISSN: 2160-4762


  6 in total

1.  Pharmacokinetic theory of cassette dosing in drug discovery screening.

Authors:  R E White; P Manitpisitkul
Journal:  Drug Metab Dispos       Date:  2001-07       Impact factor: 3.922

2.  An intravenous formulation decision tree for discovery compound formulation development.

Authors:  Yung-Chi Lee; Philip D Zocharski; Brian Samas
Journal:  Int J Pharm       Date:  2003-03-06       Impact factor: 5.875

3.  A rapid, simple, and humane method for submandibular bleeding of mice using a lancet.

Authors:  William T Golde; Peter Gollobin; Luis L Rodriguez
Journal:  Lab Anim (NY)       Date:  2005-10       Impact factor: 12.625

Review 4.  Snapshot PK: a rapid rodent in vivo preclinical screening approach.

Authors:  Bo Liu; Jonathan Chang; William P Gordon; John Isbell; Yingyao Zhou; Tove Tuntland
Journal:  Drug Discov Today       Date:  2007-11-26       Impact factor: 7.851

5.  Simultaneous pharmacokinetic screening of a mixture of compounds in the dog using API LC/MS/MS analysis for increased throughput.

Authors:  J Berman; K Halm; K Adkison; J Shaffer
Journal:  J Med Chem       Date:  1997-03-14       Impact factor: 7.446

6.  Cassette-accelerated rapid rat screen: a systematic procedure for the dosing and liquid chromatography/atmospheric pressure ionization tandem mass spectrometric analysis of new chemical entities as part of new drug discovery.

Authors:  W A Korfmacher; K A Cox; K J Ng; J Veals; Y Hsieh; S Wainhaus; L Broske; D Prelusky; A Nomeir; R E White
Journal:  Rapid Commun Mass Spectrom       Date:  2001       Impact factor: 2.419

  6 in total
  2 in total

Review 1.  Functional assays to assess the therapeutic potential of extracellular vesicles.

Authors:  Vivian V T Nguyen; Kenneth W Witwer; Marianne C Verhaar; Dirk Strunk; Bas W M van Balkom
Journal:  J Extracell Vesicles       Date:  2020-11-29

2.  Development of (E)-2-((1,4-dimethylpiperazin-2-ylidene)amino)-5-nitro-N-phenylbenzamide, ML336: Novel 2-amidinophenylbenzamides as potent inhibitors of venezuelan equine encephalitis virus.

Authors:  Chad E Schroeder; Tuanli Yao; Julie Sotsky; Robert A Smith; Sudeshna Roy; Yong-Kyu Chu; Haixun Guo; Nichole A Tower; James W Noah; Sara McKellip; Melinda Sosa; Lynn Rasmussen; Layton H Smith; E Lucile White; Jeffrey Aubé; Colleen B Jonsson; Donghoon Chung; Jennifer E Golden
Journal:  J Med Chem       Date:  2014-10-07       Impact factor: 7.446

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.